AR192370A1 - Procedimiento para la obtencion de derivados de piridazina - Google Patents

Procedimiento para la obtencion de derivados de piridazina

Info

Publication number
AR192370A1
AR192370A1 AR242634A AR24263472A AR192370A1 AR 192370 A1 AR192370 A1 AR 192370A1 AR 242634 A AR242634 A AR 242634A AR 24263472 A AR24263472 A AR 24263472A AR 192370 A1 AR192370 A1 AR 192370A1
Authority
AR
Argentina
Prior art keywords
procedure
obtaining
pyridazine derivatives
pyridazine
derivatives
Prior art date
Application number
AR242634A
Other languages
English (en)
Spanish (es)
Original Assignee
Experimentales Cliniques Cepbe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Experimentales Cliniques Cepbe filed Critical Experimentales Cliniques Cepbe
Application granted granted Critical
Publication of AR192370A1 publication Critical patent/AR192370A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR242634A 1971-06-18 1972-06-19 Procedimiento para la obtencion de derivados de piridazina AR192370A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2873771 1971-06-18
FR7219096A FR2141697B1 (xx) 1971-06-18 1972-05-29

Publications (1)

Publication Number Publication Date
AR192370A1 true AR192370A1 (es) 1973-02-14

Family

ID=26217112

Family Applications (1)

Application Number Title Priority Date Filing Date
AR242634A AR192370A1 (es) 1971-06-18 1972-06-19 Procedimiento para la obtencion de derivados de piridazina

Country Status (13)

Country Link
US (1) US4169158A (xx)
JP (1) JPS5550943B1 (xx)
AR (1) AR192370A1 (xx)
AU (1) AU472247B2 (xx)
BE (1) BE784727A (xx)
CA (1) CA1003833A (xx)
CH (1) CH546769A (xx)
DE (1) DE2229215C2 (xx)
ES (1) ES403998A1 (xx)
FR (1) FR2141697B1 (xx)
GB (1) GB1345880A (xx)
NL (1) NL177893C (xx)
SE (1) SE392899B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2511366A1 (fr) * 1981-08-11 1983-02-18 Sanofi Sa Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
FR2539741A1 (fr) * 1983-01-21 1984-07-27 Sanofi Sa Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
FR2539742B1 (fr) * 1983-01-24 1986-09-05 Sanofi Sa Derives amines de la pyridazine substitues en position 6 par un heterocycle ou un alicycle, lesdits derives etant actifs sur le systeme nerveux central
FR2539739B1 (fr) * 1983-01-24 1985-11-22 Sanofi Sa Nouveaux derives de la naphtyl pyridazine actifs sur le systeme nerveux central, procede de preparation de ces derives et medicaments en contenant
FR2555178B1 (fr) * 1983-11-18 1986-04-18 Sanofi Sa Derives cyanes de la pyridazine ayant une action psychotrope, leur mode de preparation et les medicaments en contenant
FR2540115B1 (fr) * 1983-01-28 1985-06-07 Sanofi Sa Derive de la pyridazine ayant une action psychotrope, son mode de preparation et les medicaments en contenant
US4565814A (en) * 1983-01-28 1986-01-21 Sanofi Pyridazine derivatives having a psychotropic action and compositions
FR2625201B1 (fr) * 1987-12-24 1990-06-15 Sanofi Sa Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant
PT93060B (pt) 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
FR2642757B1 (fr) * 1989-02-07 1991-05-24 Sanofi Sa Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant
US5461053A (en) * 1989-02-07 1995-10-24 Sanofi Pyridazine derivatives
FR2642648B1 (fr) * 1989-02-07 1991-06-21 Sanofi Sa Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
FR2642754B1 (fr) * 1989-02-07 1991-05-24 Sanofi Sa Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
EP1430033A4 (en) * 2001-08-31 2004-12-15 Univ Northwestern PROTEIN KINASE ANTI-INFLAMMATORY AND INHIBITOR COMPOSITION AND METHOD OF USE
WO2006050359A2 (en) 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds and methods
ES2543813T3 (es) 2004-11-02 2015-08-24 Northwestern University Compuestos de piridazina para el tratamiento de enfermedades inflamatorias
CA2614116A1 (en) * 2005-07-04 2007-01-11 Novo Nordisk A/S Novel medicaments
RU2442775C2 (ru) * 2005-07-04 2012-02-20 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
CA2650711A1 (en) 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
EP2015751A2 (en) * 2006-04-28 2009-01-21 Northwestern University Salts of pyridazine compounds
WO2007127375A2 (en) 2006-04-28 2007-11-08 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
US8318927B2 (en) 2006-05-23 2012-11-27 High Point Pharmaceuticals, Llc 6-(4-cyclopropylpiperazin-1-yl)-2′-methyl-[3, 4′]-bipyridine and its uses as a medicament
CN102295606A (zh) 2006-05-29 2011-12-28 高点制药有限责任公司 合成3-(1,3-苯并间二氧杂环戊烯-5-基)-6-(4-环丙基哌嗪-1-基)-哒嗪的方法及其适用的中间体
EP2014656A3 (en) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
US8461389B2 (en) 2008-04-18 2013-06-11 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) * 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
KR102695378B1 (ko) 2018-01-23 2024-08-16 인스티튜트 구스타브 루시 종양 성장을 감소시키기 위한 미나프린의 용도

Also Published As

Publication number Publication date
FR2141697A1 (xx) 1973-01-26
DE2229215C2 (de) 1984-09-06
NL7208355A (xx) 1972-12-20
CA1003833A (en) 1977-01-18
CH546769A (fr) 1974-03-15
US4169158A (en) 1979-09-25
BE784727A (fr) 1972-10-02
ES403998A1 (es) 1975-06-01
NL177893C (nl) 1985-12-16
GB1345880A (en) 1974-02-06
SE392899B (sv) 1977-04-25
AU472247B2 (en) 1973-12-20
AU4350072A (en) 1973-12-20
FR2141697B1 (xx) 1976-09-17
JPS5550943B1 (xx) 1980-12-20
DE2229215A1 (de) 1973-01-25
NL177893B (nl) 1985-07-16

Similar Documents

Publication Publication Date Title
AR192370A1 (es) Procedimiento para la obtencion de derivados de piridazina
AR199200A1 (es) Procedimiento para la preparacion de derivados de cetona
AR199879A1 (es) Procedimiento para la elaboracion de 4-aza-benzimidazoles
AR200387A1 (es) Procedimiento para preparar derivados de trifluorometilfenilpiperazina
AR203002A1 (es) Procedimiento para la preparacion de derivados de tetrahidrodibenzo-imidazo-azepinas
AR192765A1 (es) Procedimiento para la preparacion de derivados de la fenil-3-tiourea
AR199084A1 (es) Procedimiento para la obtencion de derivados 2-nitroimidazol
AR192914A1 (es) Procedimiento para la obtencion de compuesto yodoetinilicos
AR209571A1 (es) Procedimiento para preparar compuestos derivados de fluorenona
AR206589A1 (es) Procedimiento para la preparacion de derivados de benzocicloheptaisoquinolina
AR204899A1 (es) Procedimiento para la preparacion de 3-carbamoiloximetilcefalosporinas
AR192732A1 (es) Procedimiento para la preparacion de derivados de guanidinofenilurea
AR196408A1 (es) Procedimiento para la preparacion de derivados de tienodiazepina
AR203017A1 (es) Procedimiento para la preparacion de fenilimidazolidinonas
AR199605A1 (es) Procedimiento para preparar dihidro-2aminoisoquinolinas
AR205784A1 (es) Procedimiento para la elaboracion de penicilamina
AR209254A1 (es) Procedimiento para la preparacion de derivados de fenil-bencilcetona
AR200859A1 (es) Procedimiento para la obtencion de nuevos derivados de diazepina
AR193576A1 (es) Procedimiento para la preparacion de pirimidotriacinas
AR209577A1 (es) Procedimiento para la obtencion de 1-fenoxi-3-amino-propan-2-ol-n-sustituido
AR197050A1 (es) Procedimiento para la preparacion de sulfonilaminopirimidinas
AR198166A1 (es) Procedimiento para la obtencion de derivados de piridina
AR208273A1 (es) Procedimiento para la preparacion de derivados de nitroquinazolinona
AR203728A1 (es) Procedimiento para la preparacion de derivados de nitropirazol
AR203192A1 (es) Procedimiento para la obtencion de nuevos derivados de diazepina